In- and out-licensing
Find the right partners to add value to your products or acquire licenses
For more than 30 years, our specialized team has been supporting companies in the health industry in their projects for developing and exploiting licenses, and more particularly in the partner search for in and out licensing.
Companies that trust us
The challenges related to in and out licensing
The emerging trend of in- and out-licensing in the health industry is motivated by several factors, including the increased costs and risks associated with developing a new medication or new technology, the lack of internal expertise, and the need to enlarge ones portfolio of patents and products.
In- and out-licensing offers opportunities to biotechs and pharmas to access new technologies and products or new markets, all while reducing the associated financial and organizational risks, in order to remain competitive in constantly evolving industries.
In order to maximize the potential of in- and out-licensing, it is important to bring attention to the associated challenges, in particular:
For in licensing
In licensing is a way for companies to access innovations that complement their own R&D capacities and grow their portfolio of products and technologies to reinforce their market position and their capacity to address patient needs.
What range of products will be developed via in licensing? What are the most appropriate partners for addressing my in-licensing strategy?
By in-licensing products that are already advanced in the R&D process, companies will be able to reduce the risks associated with R&D (notably those associated with early phases of research). This allows companies to benefit from new assets while avoiding high costs of acquiring infrastructures and specific expertise.
At what stage of R&D should new products be licensed? How can my in-licensing strategy be demonstrated compared with a more traditional development process?
In-licensing allows the entry into new markets and geographies by acquiring the commercial rights for a product that has already been approved in other regions. This facilitates the reinforcement of one’s knowledge and distribution network in a previously unknown market.
What geographies should I target with an in-licensing strategy? How can I make the most of the rights acquired by in-licensing?